Last updated: 30 October 2026 | Author: Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. B. N. Singh (General Physician, MBBS MS General Surgery, 30+ years)
Muscular dystrophy (MD) is a group of inherited conditions in which muscles gradually become weaker. Families in India often ask whether there is a cure, what treatments really work, and where stem cell therapy fits in. The honest answer is that no treatment today can reverse the underlying genetic cause in every patient, but modern multidisciplinary care can slow decline, protect the heart and lungs, keep children mobile for longer and improve quality of life. This guide explains the options clearly so you can make informed decisions.
Quick Navigation
- What Is Muscular Dystrophy?
- Main Types of Muscular Dystrophy
- Symptoms and Early Warning Signs
- Diagnosis: Tests Doctors Use
- Standard Treatment and Supportive Care
- Newer Drug and Gene-Based Therapies
- Stem Cell Therapy for Muscular Dystrophy
- Muscular Dystrophy Treatment in India: Practical Guide
- How to Evaluate a Treatment Plan or Clinic
- Frequently Asked Questions
- Official References
- Related Readings
What Is Muscular Dystrophy?
In muscular dystrophy, changes (mutations) in genes responsible for muscle structure and repair cause muscle fibres to break down faster than the body can rebuild them. Over time, muscle is replaced by fat and scar tissue and strength declines. Some forms also affect the heart, breathing muscles and other organs. Severity, age of onset and speed of progression vary widely between types.
Main Types of Muscular Dystrophy
| Type | Who is usually affected | Key features |
|---|---|---|
| Duchenne (DMD) | Mostly boys; X-linked, symptoms from about age 2 to 5 | Most common childhood form; dystrophin protein is missing; progressive weakness, heart and breathing involvement |
| Becker (BMD) | Mostly boys, later onset than Duchenne | Partly working dystrophin; milder and slower course |
| Limb-girdle (LGMD) | Children to adults, both sexes | Weakness of shoulder and hip muscles; many genetic subtypes |
| Facioscapulohumeral (FSHD) | Teens and adults | Weakness of face, shoulder blade and upper arm muscles |
| Myotonic dystrophy | Adults, sometimes children | Muscle stiffness after use (myotonia), cataracts, heart rhythm problems |
| Congenital muscular dystrophy | Present at birth or in infancy | Low muscle tone, delayed milestones; some forms affect the brain |
Symptoms and Early Warning Signs
- Delayed walking or frequent falls in a young child
- Difficulty climbing stairs, running or getting up from the floor (using the hands to “climb up” the legs, known as Gowers’ sign)
- Walking on toes or a waddling gait
- Enlarged-looking calf muscles that are actually weak
- Muscle pain, stiffness or fatigue
- Learning or speech delays in some forms
- Breathlessness, poor cough or heart symptoms in later stages
If your child shows these signs, a paediatric neurologist should be consulted early. Early diagnosis opens the door to treatments, genetic counselling and clinical studies.
Diagnosis: Tests Doctors Use
- Clinical examination of strength, gait and reflexes.
- Serum creatine kinase (CK): usually markedly raised in Duchenne and Becker.
- Genetic testing: the key test. It identifies the exact mutation and type, which determines treatment eligibility.
- Muscle biopsy or muscle MRI: used when genetic testing is not conclusive.
- Heart and lung assessment: echocardiogram, ECG and breathing tests to establish a baseline.
Genetic confirmation matters because many newer therapies target specific mutations.
Standard Treatment and Supportive Care
The best outcomes are seen with coordinated care from a team rather than a single treatment.
| Care component | Role |
|---|---|
| Corticosteroids (for example prednisolone or deflazacort in Duchenne) | Can slow loss of muscle strength and prolong walking when used under specialist supervision; side effects need monitoring |
| Physiotherapy and gentle stretching | Maintains joint movement, reduces contractures and preserves function |
| Heart care | Regular cardiology review; medicines such as ACE inhibitors may be started to protect the heart |
| Respiratory care | Monitoring of lung function, cough assistance and night-time ventilation support when needed |
| Orthopaedic care | Splints, braces and, in some cases, surgery for contractures or scoliosis |
| Nutrition and bone health | Healthy weight, calcium and vitamin D, bone density monitoring especially on steroids |
| Mobility aids | Orthoses, wheelchairs and home adaptations that maintain independence |
| Psychological and educational support | Helps the child and caregivers cope and stay engaged in school and community |
| Genetic counselling | Explains inheritance and family-planning options |
Newer Drug and Gene-Based Therapies
Over the last decade, mutation-specific treatments have been approved for Duchenne muscular dystrophy in several countries. They include:
- Exon-skipping medicines (such as eteplirsen, golodirsen, viltolarsen and casimersen), which help the body make a shortened but partly working dystrophin protein in patients with specific mutations.
- Anti-inflammatory and muscle-protective drugs such as givinostat and vamorolone, which have received approvals in some regions.
- Gene therapy, where a working micro-version of the dystrophin gene is delivered to muscle. It has regulatory approval in the United States for certain patients, and safety monitoring has led to updated restrictions and warnings.
Availability, eligibility and cost in India vary and change over time, and these treatments are not suitable for every mutation or age group. Ask your neurologist or a neuromuscular centre which options, if any, apply to your child’s genetic result and whether enrolment in a clinical study is possible.
Stem Cell Therapy for Muscular Dystrophy
Stem cell research is driven by an appealing idea: replace or support damaged muscle with healthy cells or use cells that release anti-inflammatory and repair signals. Several cell types have been studied:
- Mesenchymal stem cells (MSCs): studied mainly for their ability to calm inflammation and support the muscle environment.
- Muscle-derived and satellite cells: aimed at regenerating muscle fibres, but delivering enough cells to many muscles in the body is a major technical hurdle.
- Gene-corrected cells: an experimental approach combining cell therapy with gene correction.
It is important to understand the current evidence. Most studies so far are small, early-phase or laboratory-based. Some have reported that the procedures were tolerated with some functional or quality-of-life signals, but stem cell therapy is not a proven cure for muscular dystrophy and does not replace standard medical, rehabilitative and cardiac care. Cell therapy is best viewed as a supportive or investigational option that should be offered only with proper evaluation, informed consent, documented protocols and realistic expectations. Results vary from patient to patient, and no outcome can be guaranteed.
Muscular Dystrophy Treatment in India: Practical Guide
- Get a confirmed diagnosis. Visit a paediatric or adult neurologist, get CK and genetic testing, and keep all reports together.
- Build the care team. A neurologist, cardiologist, pulmonologist, physiotherapist, orthopaedic specialist and nutritionist should be involved as the condition requires.
- Start physiotherapy and steroid decisions early as advised, especially in Duchenne.
- Check eligibility for newer therapies. Ask whether the genetic mutation qualifies for mutation-specific medicines or ongoing clinical studies.
- Monitor the heart and lungs regularly, even when the child is walking well.
- If considering stem cell therapy, discuss it openly with your primary specialist, ask for the protocol and safety information in writing, and combine it with, never in place of, standard care.
- Plan for the long term. Accessibility, school support, caregiver wellbeing and patient groups make a real difference.
How to Evaluate a Treatment Plan or Clinic
| Question to ask | Reassuring answer |
|---|---|
| Is the diagnosis genetically confirmed? | Yes, with a written report and clear type identification |
| What is the evidence for this treatment in my type of MD? | Published data explained honestly, including limitations |
| Is this a regulated clinical study or a supervised protocol? | Yes, with documented ethical approval and consent |
| What are the risks and expected benefits? | Clear discussion, no guarantees of cure |
| Will standard care continue alongside? | Yes. Steroids, physiotherapy, heart and lung care continue |
| Is follow-up included? | Yes, with scheduled monitoring and a contact for concerns |
Be cautious of promises of a complete cure, pressure to decide quickly, or advice to stop prescribed medicines.
Want to understand your options for muscular dystrophy care?
Frequently Asked Questions
Is there a permanent cure for muscular dystrophy?
Not at present. Treatments can slow progression, protect organs and improve function, and newer mutation-specific therapies are expanding options for some patients. Research is ongoing.
What is the best treatment for Duchenne muscular dystrophy in India?
The best approach is coordinated specialist care: genetic confirmation, corticosteroids when appropriate, physiotherapy, heart and lung monitoring, and access to newer therapies or clinical studies where the child is eligible.
Can stem cell therapy cure muscular dystrophy?
No. Stem cell therapy is still investigational for muscular dystrophy. It is not proven to cure the condition and should be considered only as a supportive or research-based option alongside standard care.
At what age should treatment begin?
As early as possible after diagnosis. Early physiotherapy, steroid decisions and cardiac monitoring can help preserve function for longer.
Is muscular dystrophy always inherited?
Most forms are inherited, but some cases arise from new mutations. Genetic counselling helps families understand risks for relatives and future pregnancies.
Which tests should be done before considering any advanced therapy?
Genetic testing, CK levels, a heart evaluation (ECG and echocardiogram) and lung function assessment are the basic tests, along with a neurological assessment of strength and mobility.
Can adults with muscular dystrophy benefit from treatment?
Yes. Supportive care, physiotherapy, cardiac and respiratory monitoring, and aids for mobility are valuable at any age, and some clinical studies include adults.
Official References
- NINDS (U.S. National Institutes of Health): Muscular Dystrophy
- MedlinePlus: Muscular Dystrophy
- GeneReviews (NCBI): Dystrophinopathies
- ClinicalTrials.gov: registry of clinical studies
- ISSCR: A Closer Look at Stem Cells (patient information)
